Cargando…
Impact of initial dialysis modality on mortality: a propensity-matched study
BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of perit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628291/ https://www.ncbi.nlm.nih.gov/pubmed/26519164 http://dx.doi.org/10.1186/s12882-015-0175-5 |
_version_ | 1782398422464069632 |
---|---|
author | Waldum-Grevbo, Bård Leivestad, Torbjørn Reisæter, Anna V Os, Ingrid |
author_facet | Waldum-Grevbo, Bård Leivestad, Torbjørn Reisæter, Anna V Os, Ingrid |
author_sort | Waldum-Grevbo, Bård |
collection | PubMed |
description | BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of peritoneal (PD) opposed to haemodialysis (HD) on all-cause and cardiovascular mortality. METHODS: To correct for case-mix differences between patients treated with PD and HD, propensity-matched analyses were utilized in all patients who initiated dialysis as first renal replacement therapy in Norway in the period 2005–2012. PD patients were matched in a 1:1 fashion with HD patients, creating 692 pairs of patients with comparable baseline variables. As-treated and intention-to treat analyses were undertaken to assess cardiovascular and all-cause mortality. Interaction analyses were used to assess differences in the relationship between initial dialysis modality and mortality, between strata of age, gender and prevalent diabetes mellitus. RESULTS: In the as-treated analyses, initial dialysis modality did not impact 2-year (PD vs. HD: HR 0.87, 95 % CI 0.67–1.12) or 5-year all-cause mortality (HR 0.95, 95 % CI 0.77–1.17). In patients younger than 65 years, PD was superior compared to HD with regard to both 2-year (HR 0.39, 95 % CI 0.19–0.81), and 5-year all-cause mortality (HR 0.49, 95 % CI 0.27–0.89). Cardiovascular mortality was also lower in the younger patients treated with PD (5-year HR 0.38, 95 % CI 0.15–0.96). PD was not associated with impaired prognosis in any of the prespecified subgroups compared to HD. The results were similar in the as-treated and intention-to-treat analyses. CONCLUSION: Survival in PD was not inferior to HD in any subgroup of patients even after five years of follow-up. In patients below 65 years, PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged. |
format | Online Article Text |
id | pubmed-4628291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46282912015-11-01 Impact of initial dialysis modality on mortality: a propensity-matched study Waldum-Grevbo, Bård Leivestad, Torbjørn Reisæter, Anna V Os, Ingrid BMC Nephrol Research Article BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of peritoneal (PD) opposed to haemodialysis (HD) on all-cause and cardiovascular mortality. METHODS: To correct for case-mix differences between patients treated with PD and HD, propensity-matched analyses were utilized in all patients who initiated dialysis as first renal replacement therapy in Norway in the period 2005–2012. PD patients were matched in a 1:1 fashion with HD patients, creating 692 pairs of patients with comparable baseline variables. As-treated and intention-to treat analyses were undertaken to assess cardiovascular and all-cause mortality. Interaction analyses were used to assess differences in the relationship between initial dialysis modality and mortality, between strata of age, gender and prevalent diabetes mellitus. RESULTS: In the as-treated analyses, initial dialysis modality did not impact 2-year (PD vs. HD: HR 0.87, 95 % CI 0.67–1.12) or 5-year all-cause mortality (HR 0.95, 95 % CI 0.77–1.17). In patients younger than 65 years, PD was superior compared to HD with regard to both 2-year (HR 0.39, 95 % CI 0.19–0.81), and 5-year all-cause mortality (HR 0.49, 95 % CI 0.27–0.89). Cardiovascular mortality was also lower in the younger patients treated with PD (5-year HR 0.38, 95 % CI 0.15–0.96). PD was not associated with impaired prognosis in any of the prespecified subgroups compared to HD. The results were similar in the as-treated and intention-to-treat analyses. CONCLUSION: Survival in PD was not inferior to HD in any subgroup of patients even after five years of follow-up. In patients below 65 years, PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged. BioMed Central 2015-10-30 /pmc/articles/PMC4628291/ /pubmed/26519164 http://dx.doi.org/10.1186/s12882-015-0175-5 Text en © Waldum-Grevbo et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Waldum-Grevbo, Bård Leivestad, Torbjørn Reisæter, Anna V Os, Ingrid Impact of initial dialysis modality on mortality: a propensity-matched study |
title | Impact of initial dialysis modality on mortality: a propensity-matched study |
title_full | Impact of initial dialysis modality on mortality: a propensity-matched study |
title_fullStr | Impact of initial dialysis modality on mortality: a propensity-matched study |
title_full_unstemmed | Impact of initial dialysis modality on mortality: a propensity-matched study |
title_short | Impact of initial dialysis modality on mortality: a propensity-matched study |
title_sort | impact of initial dialysis modality on mortality: a propensity-matched study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628291/ https://www.ncbi.nlm.nih.gov/pubmed/26519164 http://dx.doi.org/10.1186/s12882-015-0175-5 |
work_keys_str_mv | AT waldumgrevbobard impactofinitialdialysismodalityonmortalityapropensitymatchedstudy AT leivestadtorbjørn impactofinitialdialysismodalityonmortalityapropensitymatchedstudy AT reisæterannav impactofinitialdialysismodalityonmortalityapropensitymatchedstudy AT osingrid impactofinitialdialysismodalityonmortalityapropensitymatchedstudy |